TABLE 4.
Variableb | Effect on Slope |
||
---|---|---|---|
β | t | p | |
Age | 0.049 | 1.014 | 0.311 |
Gender | 0.014 | 0.310 | 0.757 |
Age of onset | −0.080 | −1.728 | 0.085 |
Total Medication Trials | 0.023 | 0.470 | 0.638 |
Total Medical Comorbidities* | 0.128 | 2.564 | 0.011 |
Total Psychiatric Comorbidities | 0.009 | 0.181 | 0.856 |
Checking | 0.035 | 0.651 | 0.515 |
Hoarding | 0.021 | 0.385 | 0.700 |
Neutralizing | 0.079 | 1.506 | 0.133 |
Ordering | 0.043 | 0.736 | 0.462 |
Washing | 0.076 | 1.461 | 0.145 |
Obsessing* | −0.126 | −2.472 | 0.014 |
p < .05
based on YBOC-CS scores; higher score=greater perceived benefit
Variables of a priori interest (age, gender, OCI-R subscales) and those correlated with YBOC-CS at p<.1 were entered simultaneously into the model